FinePG, PortenoyRK. for the Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation: Establishing “best practices” for opioid rotation: Conclusions for an expert panel. J Pain Symptom Manage, 2009; 38:418–425.
4.
ShaheenPE, WalshD, LasheenW, DavisMP, LagmanRL. Opioid equianalgesic tables: are they all equally dangerous?J Pain Symptom Manage, 2009; 38:409–417.
KnotknovaH, FinePG, PortenoyRK. Opioid rotation: The science and the limitations of the equianalgesic dose table. J Pain Symptom Manage, 2009; 38:426–439.
7.
MahlerDL, ForrestWH. Relative analgesic potencies of morphine and hydromorphone in postoperative pain. Anesthesiology, 1975; 42:602–607.
LawlorP, TurnerK, HansonJ, BrueraE. Dose ratio between morphine and hydromorphone in patients with cancer pain: A retrospective study. Pain, 1997; 72:79–85.
11.
DunbarPJ, ChapmanCR, BuckleyFP, GavrinJR. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain, 1996; 68:265–270.
12.
CollinsJJ, GeakeJ, GrierHE, HouckCS, ThalerHT, WeinsteinHJ, Twum-DansoNY, BerdeCB. Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphone. J Pediatr, 1996; 129:722–730.
13.
CodaBA, O'SullivanB, DonaldsonG, BohlS, ChapmanCR, ShenDD. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain, 1997; 72:333–346.
14.
MillerMG, McCarthyN, O'BoyleCA, KearneyM. Continuous subcutaneous infusion of morphine vs hydromorphone: A controlled trial. J Pain Symptom Manage, 1999; 18:9–16.
15.
PereiraJ, LawlorP, ViganoA, DorganM, BrueraE. Equianalgesic dose ratios for opioids: A critical review and proposals for long-term dosing. J Pain Symptom Manage, 2001; 22:672–687.
16.
GagnonB, BielechM, WatanabeS, WalkerP, HansonJ, BrueraE. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer, 1999; 7:265–270.
17.
WatanabeS, PereiraJ, HansonJ, BrueraE. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: A retrospective study. J Pain Symptom Manage, 1998; 16:323–326.
